{"abstract": "Biogen Idec on Thursday rejected billionaire investor Carl C. Icahn\u2019s proposed slate of corporate directors, setting the stage for a proxy fight for control of the biotechnology company\u2019s board.", "web_url": "https://dealbook.nytimes.com/2008/04/18/bioegn-idec-rejects-icahn-slate-as-unsuitable/", "snippet": "", "lead_paragraph": "Biogen Idec on Thursday rejected billionaire investor Carl C. Icahn\u2019s proposed slate of corporate directors, setting the stage for a proxy fight for control of the biotechnology company\u2019s board.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Bioegn Idec Rejects Icahn Slate as Unsuitable", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2008-04-18T10:31:08+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/52e01848-37d4-56aa-b88c-58cedc0df7b0", "word_count": 378, "uri": "nyt://article/52e01848-37d4-56aa-b88c-58cedc0df7b0"}